Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
AVR
Anteris Technologies Global Corp.
Anteris Technologies Global Corp. (AVR) is rated C (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Value (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.5
/ 5.0
C
Value
D
Factor Score
1.5
/ 5.0
Growth
B-
Factor Score
3.0
/ 5.0
Profitability
B-
Factor Score
3.0
/ 5.0
Momentum
C
Factor Score
2.2
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-4.9
EV / EBITDA
-3.0
Rev Growth YoY
21.0%
Gross Margin
75.8%
Price Return 3M
-40.5%
Price Return 12M
50.4%
Catalyst Signal
0.00
Market Cap
$555.7M
TTM Revenue
$2.3M
Price / Sales
238.3
ROE
-93.3%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | D (1.5) | B- (3.0) | B- (3.0) | C (2.2) | C+ (2.6) | C (2.5) |
| 2026-11-10 | D (1.3) | B (3.2) | B- (3.1) | C+ (2.6) | C+ (2.6) | C+ (2.6) |
| 2026-11-03 | D (1.4) | B (3.2) | B- (3.0) | B- (3.1) | C+ (2.7) | C+ (2.7) |
| 2026-10-27 | D+ (1.5) | B (3.2) | B- (3.0) | B- (2.9) | C+ (2.6) | C+ (2.6) |
| 2026-10-20 | D (1.5) | B (3.2) | B- (3.0) | B- (3.0) | C+ (2.6) | C+ (2.7) |
Page
1
of
4